Golden State Equity Partners’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.15K Buy
+10
New +$1.08K ﹤0.01% 1976
2026
Q2
– Sell
-8
Closed -$322 – 608
2026
Q1
$322 Buy
+8
New +$299 ﹤0.01% 1925

Other funds holding CORT

Golden State Equity Partners's CORT Position: Q3 2026 in Review

Golden State Equity Partners opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 10 shares worth $1.15K. The stake represents ﹤0.01% of the portfolio and ranks #1976 among its holdings. This is a return to the name: Golden State Equity Partners previously reported a position in CORT as recently as Q1 2026.

Golden State Equity Partners first reported a position in CORT in Q1 2026 and has held it in 2 quarters since. 502 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Golden State Equity Partners held 10 shares of Corcept Therapeutics worth $1.15K as of Q3 2026.
  • Corcept Therapeutics was a new Golden State Equity Partners position in Q3 2026.
  • Corcept Therapeutics made up ﹤0.01% of Golden State Equity Partners's portfolio in Q3 2026, its #1976 holding.
  • Golden State Equity Partners first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 502 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Golden State Equity Partners's 13F filing for Q3 2026, filed 3 Nov 2026.